Paris and Boston, June 14, 2017 – 17: 45 – Mauna Kea Technologies (Euronext:
Nantes, 14 June 2017, 18 hours – OSE Immunotherapeutics AG (ISIN: FR0012127173; Mnémo: OSE),
The part in the dose escalation of the Phase I trial has been the
In partnership with many incubators, DS has created the first contest proposed by a
On the eve of the International exhibition of Aeronautics and Space (SIAE) Paris-Le Bourget,
ADLPartner renews its eligibility to the device PEA-PME for the coming twelve months in
Paris, June 15, 2017 at 8: 00 a.m. (CEST) – ABIVAX (Euronext Paris :
In the framework of its development strategy, the Group Prunay and its subsidiary Maisoning
Spineway, a specialist in implants and ancillary surgery for the treatment of pathologies of
Further to its press release, 12 June 2017, Sequana provides the following details relating